Epilepsy is a neurological disorder characterized by recurrent seizures, which are sudden and uncontrollable bursts of electrical activity in the brain. These seizures can vary widely in severity, duration, and type, and may manifest as convulsions, temporary confusion, or loss of consciousness. While the exact cause of epilepsy is often unknown, it can be triggered by factors such as brain injury, genetics, infections, or developmental disorders. Treatment for epilepsy typically involves medications to control seizures, lifestyle modifications, and in some cases, surgical interventions to remove or isolate affected brain tissue.
Patients are the experts in their condition and advocacy groups provide a platform for patient voices. Working directly with these communities is the key to pushing research forward in an inclusive way.
We’ve committed to having 500,000 conversations in the next three years, to equip ourselves and our Pharma partners with the insights needed to increase predictability.
Read more...
The ever-growing investment in advocacy doesn’t appear to be slowing down, and research is certainly seeing the benefits. Which at the end of the day, means better patient care and more options for patients.
Read more...
We’re ready to keep forming links between our Advocacy friends and Pharma partners, so these fruitful relationships continue to evolve beyond the study-to-study view.
Read more...